Healthcare Attys Turn Attention To Material Adverse Change

By Yeji Jesse Lee · April 30, 2024, 10:26 PM EDT

Life sciences companies are focusing on a specific clause in M&A contracts to prevent unexpected disruptions from tanking deals, according to attorneys working on transactions in the healthcare industry....

To view the full article, register now.